Sebia logo — A Global specialized In Vitro Diagnostic player

Sebia

A Global specialized In Vitro Diagnostic player

Founded 1967 France France 555 employees Private Equity Biotechnology, Health Care

General Information

Company Name Sebia
Founded Year 1967
Location France France +1
Employees 555
Industries Biotechnology, Health Care
Funding Stage Private Equity
Social

Get notified when Sebia moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sebia

Sebia is a global leader in the specialty In Vitro Diagnostic industry, focusing on screening and monitoring diseases in areas such as Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy, Autoimmunity, and other rare pathologies. The company was founded in 1967 and is headquartered in the South of Paris, France. Sebia's mission is to provide powerful tools that can interpret what is happening in a patient's body, effectively establishing a new language of life. The company is known for setting high standards in technologies, scientific excellence, and manufacturing capabilities, allowing it to continuously advance and maintain an exciting pipeline of new tests and automated equipment. Moreover, Sebia secured a Private Equity Round investment on 11th August 2017, with the funding coming from Caisse de Depot et Placement du Quebec. The company operates in the Biotechnology and Health Care industries, showcasing a lasting commitment to making a meaningful impact in the field of healthcare diagnostics.

Taxonomy: In Vitro Diagnostics, Oncology, Diabetes, Hemoglobinopathy, Autoimmunity, Rare Pathologies, Clinical Protein Electrophoresis, Diagnostic Solutions, Automated Equipment, Medical Diagnostics, Laboratory Diagnostics, Capillary Electrophoresis, Gel Electrophoresis, ELISA, Mass Spectrometry

Services & Products

Provision of diagnostic equipment
tests
software
and educational resources for healthcare professionals in the field of metabolic and autoimmune diseases.

Target Customers

Healthcare professionals clinical laboratories medical researchers and healthcare institutions worldwide.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round •••••• 1 •••• •••• 11 Aug 2017
Private Equity Round •••••• 3
Investor Investor
•••• ••••
03 Jun 2014

Sebia Alternatives & Competitors

Sebia vs

We innovate diagnostic efficiency

65 employees
Internet, Manufacturing
Sebia vs
Lifescan Health
Lifescan Health United States

Live better with Lifescan

86 employees
Sebia vs
MEDTEK
MEDTEK Philippines

Confidence in Medical Diagnostics

83 employees

FAQ About Sebia

A Global specialized In Vitro Diagnostic player
Sebia was founded in 1967.
Sebia is headquartered in France.
Sebia operates in the following industries: Biotechnology, Health Care.
Sebia has approximately 555 employees.
Sebia has completed 2 funding rounds. The latest funding stage is Private Equity.
Sebia offers: Provision of diagnostic equipment, tests, software, and educational resources for healthcare professionals in the field of metabolic and autoimmune diseases..
Top alternatives and competitors to Sebia include Gentian Diagnostics , Lifescan Health, MEDTEK, ALA Diagnostics, S.L., Ring Biotechnology Co Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sebia and Gentian Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sebia and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy